Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Heckmatt, J
Right arrow Articles by Dubowitz, V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heckmatt, J
Right arrow Articles by Dubowitz, V
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 45:788-801 (1989)
© 1989 The British Council

research-article

Management of children: Pharmacological and physical

J Heckmatt, E Rodillo and V Dubowitz

Department of Paediatrics & Ferry Lewis Muscle Research Laboratories, Royal postgraduate Medical School, Hammersmith Hospital London, UK

Abstract

In the absence of any effective drug treatment, physical mehods of management are still the mainstay of treatment. Our current practice in Duchenne muscular dystrophy is to provide lightweight knee-anke-foot orthoses at the time of loss of ambulation. This prolongs independent walking for an average of two years, and has the effect of delaying the onset of scolisis, particularly if the body remains ambulant during the pubertal growth spurt. We are currently assessing the value of radical surgery, performed early in the courses of the disease, which may stablize and prolong independent walking. In non-ambulant patients instrumentation of the spine, using mainly the Luque technique, has revolutionised the treatment of progressive scoliosis.

Ventilator support produces clinical improvement in late cases with symptomatic hypoventilation. Its place in the management of symptomatic hypoventilation. Its place in the management of asymptomatic patients with nocturnal hypoventilation still needs evaluation, as does the role of early prophylatic respiratory support.

We have reviewed the clinical drug trials over the past 10 years. There has been an overall improvement in their quality control.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JBJSHome page
P. J. VIGNOS JR., M. B. WAGNER, B. KARLINCHAK, and B. KATIRJI
Evaluation of a Program for Long-Term Treatment of Duchenne Muscular Dystrophy. Experience at the University Hospitals of Cleveland
J. Bone Joint Surg. Am., December 1, 1996; 78(12): 1844 - 52.
[Abstract] [Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.